京東方A(000725.SZ)擬發行不超20億元可續期公司債券
格隆匯4月21日丨京東方A(000725.SZ)發佈2020年公開發行可續期公司債券(面向合格投資者)(第三期)(疫情防控債)發行公告,發行規模不超過20億元。
本期債券基礎期限為3年,在約定的基礎期限末及每個續期的週期末,公司有權行使續期選擇權,按約定的基礎期限延長1個週期,在公司不行使續期選擇權全額兑付時到期。
本期債券詢價區間為3.00%-4.00%,發行人和主承銷商將於2020年4月23日向網下合格投資者利率詢價,並根據利率詢價情況確定本期債券的最終票面利率。發行人和主承銷商將於2020年4月24日公告本期債券的最終票面利率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.